Company registration number 14475689 (England and Wales)
CERES DIAGNOSTICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024
PAGES FOR FILING WITH REGISTRAR
CERES DIAGNOSTICS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
CERES DIAGNOSTICS LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2024
30 November 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
4
10,835
9,561
Creditors: amounts falling due within one year
5
(36,139)
(24,052)
Net current liabilities
(25,304)
(14,491)
Capital and reserves
Called up share capital
6
-
0
-
0
Profit and loss reserves
(25,304)
(14,491)
Total equity
(25,304)
(14,491)

For the financial year ended 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 8 May 2025
Mr A R King
Director
Company registration number 14475689 (England and Wales)
CERES DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024
- 2 -
1
Accounting policies
Company information

Ceres Diagnostics Limited is a private company limited by shares incorporated in England and Wales. The registered office is 34 High Street, Aldridge, Walsall, West Midlands, WS9 8LZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

These financial statements are prepared on the going concern basis. The director has a reasonable expectation that the company will continue in operational existence for the foreseeable future.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include other debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

CERES DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2024
1
Accounting policies
(Continued)
- 3 -
Basic financial liabilities

Basic financial liabilities, including trade creditors and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.4
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
-
0
-
0
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
10,835
9,561
CERES DIAGNOSTICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2024
- 4 -
5
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
30,704
-
0
Other creditors
5,435
24,052
36,139
24,052
6
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and unpaid
Ordinary shares of 0.1p each
1
1
-
0
-
0
7
Related party transactions

Included within creditors falling due within one year is a balance of £65 (2023: £Nil) due to a related company under the common control of a director. This balance is interest free and repayable on demand.

 

Included within debtors falling due within one year is a balance of £62 (2023: creditor £23,552) due from a related company under the common control of a director. This balance is interest free and repayable on demand.

2024-11-302023-12-01falsefalsefalse08 May 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityMr A R King2025-05-08144756892023-12-012024-11-30144756892024-11-30144756892023-11-3014475689core:CurrentFinancialInstrumentscore:WithinOneYear2024-11-3014475689core:CurrentFinancialInstrumentscore:WithinOneYear2023-11-3014475689core:CurrentFinancialInstruments2024-11-3014475689core:CurrentFinancialInstruments2023-11-3014475689core:ShareCapital2024-11-3014475689core:ShareCapital2023-11-3014475689core:RetainedEarningsAccumulatedLosses2024-11-3014475689core:RetainedEarningsAccumulatedLosses2023-11-3014475689core:ShareCapitalOrdinaryShareClass12024-11-3014475689core:ShareCapitalOrdinaryShareClass12023-11-3014475689bus:Director12023-12-012024-11-30144756892022-11-102023-11-3014475689core:WithinOneYear2024-11-3014475689core:WithinOneYear2023-11-3014475689bus:OrdinaryShareClass12023-12-012024-11-3014475689bus:OrdinaryShareClass12024-11-3014475689bus:OrdinaryShareClass12023-11-3014475689bus:PrivateLimitedCompanyLtd2023-12-012024-11-3014475689bus:SmallCompaniesRegimeForAccounts2023-12-012024-11-3014475689bus:FRS1022023-12-012024-11-3014475689bus:AuditExemptWithAccountantsReport2023-12-012024-11-3014475689bus:FullAccounts2023-12-012024-11-30xbrli:purexbrli:sharesiso4217:GBP